Healthcare Services

A key trend shaping the Addictions Therapeutics Market Global Report 2026 Market involves the Innovative Breakthroughs In Addiction Therapeutics Market

March 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Addictions Therapeutics Market Over The Period 2026–2030?

The addictions therapeutics market has demonstrated substantial growth in its size over recent years. It is anticipated to expand from $7.46 billion in 2025 to $7.93 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.2%. The historical increase can be ascribed to elements such as the increasing prevalence of substance use disorders, heightened awareness concerning addiction treatment, an expanding number of specialized treatment centers, the uptake of buprenorphine and naltrexone therapies, and the broader reach of hospital and clinical networks.

The addictions therapeutics market size is projected to demonstrate strong growth over the next few years, expanding to $10.24 billion by 2030 at a compound annual growth rate (CAGR) of 6.6%. This growth in the forecast period is attributable to the development of novel addiction therapeutics, increased government and private funding for suds programs, the rise of telehealth and digital treatment platforms, a growing integration of mental health and addiction therapies, and the expansion of public-private partnerships in addiction care. Furthermore, major trends anticipated in the forecast period include a rising demand for medication-assisted treatment (mat), the expansion of both inpatient and outpatient addiction treatment centers, increasing adoption of telehealth and remote counseling services, a concentrated focus on nicotine and opioid addiction therapies, and enhanced awareness programs for substance use disorders.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12129&type=smp

Which Major Factors Are Driving The Expansion Of The Addictions Therapeutics Market?

A rise in alcohol consumption is anticipated to drive the expansion of the addiction therapeutics market in the future. Alcohol consumption is defined as the act of consuming beverages that contain ethyl alcohol. These therapeutics are employed to manage alcohol addiction, helping individuals reduce their intake by counteracting alcohol’s depressive impacts and fostering equilibrium between the excitatory neurotransmitter glutamate and the inhibitory neurotransmitter gamma-aminobutyric acid. This action lessens cravings for alcohol, mitigates associated symptoms, and suppresses withdrawal manifestations such as insomnia, anxiety, and restlessness. For example, Kirin Holdings Co. Ltd., a Japanese company specializing in alcoholic, non-alcoholic beverages, and pharmaceuticals, reported in December 2024 that global beer consumption in 2023 experienced a minor increase of approximately 200,000 kl from 2022, totaling around 187.9 million kl. This amount is equivalent to roughly 296.9 billion 633 ml bottles, indicating a slight year-over-year growth of 0.1%. Consequently, the rising consumption of alcohol is fueling the addiction therapeutics market.

How Is The Addictions Therapeutics Market Divided Into Its Major Segments?

The addictions therapeutics market covered in this report is segmented –

1) By Drug Type: Buprenorphine, Naltrexone, Bupropion, Disulfiram, Nicotine Replacement Products, Varenicline, Other Drugs

2) By Treatment Type: Opioid Addiction Treatment, Alcohol Addiction Treatment, Nicotine Addiction Treatment, Other Substance Addiction Treatment

3) By Treatment Center: Inpatient Treatment Center, Residential Treatment Center, Outpatient Treatment Center

4) By Distribution Channel: Hospital Pharmacies, Medical Stores, Other Distribution Channel

Subsegments:

1) By Buprenorphine: Subutex, Suboxone

2) By Naltrexone: Oral Naltrexone, Extended-Release Naltrexone (Vivitrol)

3) By Bupropion: Wellbutrin, Zyban

4) By Disulfiram: Antabuse, Generic Disulfiram

5) By Nicotine Replacement Products: Nicotine Patches, Nicotine Gum, Nicotine Inhalers, Nicotine Lozenges

6) By Varenicline: Chantix (Champix), Generic Varenicline

7) By Other Drugs: Acamprosate, Topiramate, Gabapentin

How Are Trends Transforming The Addictions Therapeutics Market Landscape?

Leading companies in the addiction therapeutics market are actively developing innovative products, such as medications for cocaine use disorders (CUD), to cater to broader customer bases, drive increased sales, and boost revenue. Drugs for cocaine use disorders (CUD) are pharmaceutical interventions crafted to support individuals grappling with cocaine addiction or dependence. For instance, in January 2023, Tempero Bio, a biopharmaceutical company headquartered in the US, announced the U.S. Food and Drug Administration (FDA) approval for TMP-301. The distinct feature of TMP-301, the Company’s investigational drug candidate, is its function as a metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM). Specifically developed for a significant role in the treatment of cocaine use disorders (CUD), TMP-301 is notable for its potency, selectivity, and oral availability, all geared towards effectively moderating the overactive glutamate signaling associated with CUD.

Who Are The Prominent Organizations Shaping The Addictions Therapeutics Market?

Major companies operating in the addictions therapeutics market are Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Mylan N.V., Bausch Health Companies Inc., Sun Pharmaceutical Industries Limited, Perrigo Company plc, Purdue Pharma L.P., Dr. Reddy’s Laboratories Ltd., Cipla Inc., Hikma Pharmaceuticals plc, Amneal Pharmaceuticals Inc., Mallinckrodt Plc, Alkermes plc., Glenmark Pharmaceuticals Limited, Indivior plc., Lannett Company Inc., BioDelivery Sciences International Inc., Camurus AB, Orexo AB, Elite Pharmaceuticals Inc., Braeburn Inc., Titan Pharmaceuticals Inc., BioCorRx Inc.

Read the full addictions therapeutics market report here:

https://www.thebusinessresearchcompany.com/report/addictions-therapeutics-global-market-report

Which Region Currently Holds The Largest Share Of The Addictions Therapeutics Market?

North America was the largest region in the addictions therapeutics market in 2025. The regions covered in the addictions therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Addictions Therapeutics Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=12129&type=smp

Browse Through More Reports Similar to the Global Addictions Therapeutics Market 2026, By The Business Research Company

substance abuse and addiction treatment global market report

https://www.thebusinessresearchcompany.com/report/substance-abuse-and-addiction-treatment-global-market-report

nicotine addiction treatment global market report

https://www.thebusinessresearchcompany.com/report/nicotine-addiction-treatment-global-market-report

substance abuse and addiction treatment global market report

https://www.thebusinessresearchcompany.com/report/substance-abuse-and-addiction-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795